Medical Developments International Limited (MVP.AX)
ASX · AUD · Healthcare · Drug Manufacturers - Specialty & Generic
A$0.3725 (+2.05%) as of
Key statistics
- Market cap
- 41.97M
- P/E (TTM)
- 37.25
- Forward P/E
- 9.95
- EPS (TTM)
- 0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.3650 – 0.7200
- Beta
- 1.56
- Revenue (TTM)
- 42.57M
- Profit margin
- 1.47%
- Analyst target
- A$2.30
- Volume
- 37.80k
About Medical Developments International Limited
Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The company also supplies respiratory products, including space chambers, peak flow meters, portable nebulizers, and silicone face masks to aid sufferers of asthma and chronic obstructive pulmonary disease. Medical Developments International Limited was founded in 1972 and is headquartered in Scoresby, Australia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Scoresby, VIC, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.